Stock 002262 JIANGSU NHWA PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
25.01 CNY -0.28% Intraday chart for Jiangsu Nhwa Pharmaceutical Co., LTD +7.39% -7.78%
19/04 Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03/04 Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets MT

Business Summary

Jiangsu Nhwa Pharmaceutical Co., LTD is a China-based company principally engaged in the production and sales of pharmaceutical preparations. The Company offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The Company is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 5,394

Sales per Business

CNY in Million2022Weight2023Weight Delta
Manufacturing
84.6 %
3,710 86.3 % 4,263 84.6 % +14.91%
Commercial
14.5 %
523 12.2 % 731 14.5 % +39.77%
Other
0.9 %
65 1.5 % 47 0.9 % -27.68%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.8 %
4,282 99.6 % 4,967 99.8 % +15.99%
International
0.2 %
16 0.4 % 9 0.2 % -46.00%

Managers

Managers TitleAgeSince
Jia Quan Sun CEO
 Chief Executive Officer 47 26/10/26
Gang Sheng Li DFI
 Director of Finance/CFO 44 26/22/26
Zi Liang Yang BRD
 Director/Board Member 60 23/07/23
Zeng Liang Chen BRD
 Director/Board Member 61 23/07/23
Qing Fu BRD
 Director/Board Member 62 23/07/23
Ji Ye Wu IRC
 Investor Relations Contact - -
Bao Zhou Duan SEC
 Corporate Secretary 57 25/08/25

Members of the board

Members of the board TitleAgeSince
Peng Sheng Sun CHM
 Chairman 65 23/07/23
Qing Fu BRD
 Director/Board Member 62 23/07/23
Zeng Liang Chen BRD
 Director/Board Member 61 23/07/23
Zi Liang Yang BRD
 Director/Board Member 60 23/07/23
Xiao Xing Yin BRD
 Director/Board Member 58 01/07/01
Feng Shou Wang CHM
 Chairman 62 23/07/23
Xing Lei Jia BRD
 Director/Board Member 55 23/07/23
Yu Lan Li BRD
 Director/Board Member 73 22/13/22
Xiao Chen Qian BRD
 Director/Board Member 61 22/13/22
Guo Xiang Chen BRD
 Director/Board Member 59 29/22/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,007,588,092 485,535,871 ( 48.19 %) 0 48.19 %

Shareholders

NameEquities%Valuation
Xuzhou Enhua Investment Co. Ltd.
36.45 %
320,096,321 36.45 % 992 M ¥
Xu Zhang
2.442 %
21,444,500 2.442 % 66 M ¥
Zhong Ou Asset Management Co., Ltd
1.935 %
16,992,726 1.935 % 53 M ¥
Fullgoal Fund Management Co., Ltd.
1.927 %
16,925,507 1.927 % 52 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
1.843 %
16,189,183 1.843 % 50 M ¥
Wu Sheng Ma
1.417 %
12,442,708 1.417 % 39 M ¥
Peng Sheng Sun
1.409 %
12,375,160 1.409 % 38 M ¥
National Social Insurance Fund Portfolio 418
1.409 %
12,375,160 1.409 % 38 M ¥
Zeng Liang Chen
1.137 %
9,982,148 1.137 % 31 M ¥
Qing Fu
1.137 %
9,982,147 1.137 % 31 M ¥
NameEquities%Valuation
Peng Sheng Sun
29.50 %
37,125,478 29.50 % 115 M ¥
Zeng Liang Chen
23.80 %
29,946,442 23.80 % 93 M ¥
Qing Fu
23.80 %
29,946,440 23.80 % 93 M ¥
Zi Liang Yang
22.37 %
28,149,326 22.37 % 87 M ¥

Company contact information

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Enhua Technology Building 31 Longhu West Road

221009, Xuzhou

+

http://www.nhwa-group.com
address Jiangsu Nhwa Pharmaceutical Co., LTD(002262)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Jiangsu Nhwa Pharmaceutical Co., LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
25.01 CNY
Average target price
32.21 CNY
Spread / Average Target
+28.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU NHWA PHARMACEUTICAL CO., LTD Stock Jiangsu Nhwa Pharmaceutical Co., LTD
-7.78% 3.48B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.13% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.27% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.35% 326B
ABBVIE INC. Stock AbbVie Inc.
+3.31% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.38% 236B
NOVARTIS AG Stock Novartis AG
+4.60% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.60% 194B
PFIZER, INC. Stock Pfizer, Inc.
-4.53% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002262 Stock
  4. Company Jiangsu Nhwa Pharmaceutical Co., LTD